Europe · General news · elDiario.es

El mercado de fármacos contra la obesidad sigue creciendo con la pastilla de Wegovy

Published by elDiario.es · Spain 1 h ago

Novo Nordisk lanzá en España el "único agonista del recepto de GLP-1 en formato oral" de la misma familia que Ozempic y que, "con intervencioes sobre el estilo de vida", provoca…

Read the full article on elDiario.es Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.eldiario.es)

Also worth reading

Climate Home News

Brazil’s fossil fuel roadmap sketches out first global timetable

Daily Mail

White Lives Matter fundraiser nets $30k for suspect accused of shoving Indian man wearing turban and shouting: 'Go back to your country'

Evening Standard

King stops short of offering formal apology over transatlantic slave trade

Daily Mirror

Bomb threats on planes: Manchester and Heathrow flights among seven targeted

The Independent

Giant crater seen where Learjet crashed into ground in Florida killing all nine on board

Metro